These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12749894)

  • 1. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Koch DJ; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1903-5. PubMed ID: 12749894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Atkinson ST; Hertel LW; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3939-42. PubMed ID: 14592479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Koch DJ; Atkinson ST; Hertel LW; Nelson DL; Wainscott DB; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2393-7. PubMed ID: 12824042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4.
    Rocco VP; Spinazze PG; Kohn TJ; Honigschmidt NA; Nelson DL; Bradley Wainscott D; Ahmad LJ; Shaw J; Threlkeld PG; Wong DT; Takeuchi K
    Bioorg Med Chem Lett; 2004 May; 14(10):2653-6. PubMed ID: 15109671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5.
    Takeuchi K; Kohn TJ; Honigschmidt NA; Rocco VP; Spinazze PG; Hemrick-Luecke SK; Thompson LK; Evans DC; Rasmussen K; Koger D; Lodge D; Martin LJ; Shaw J; Threlkeld PG; Wong DT
    Bioorg Med Chem Lett; 2006 May; 16(9):2347-51. PubMed ID: 16298130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 3-[4-(2,3-dihydro-14-benzodioxin-5-yl)piperazin-1-yl]-1-(5-substituted benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT(1A) serotonin receptors and serotonin transporter as a new class of antidepressants.
    Silanes SP; Orús L; Oficialdegui AM; Martínez Esparza J; Lasheras B; Del Río J; Monge A
    Pharmazie; 2004 Jul; 59(7):499-501. PubMed ID: 15296084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.
    Shen Z; Siva Ramamoorthy P; Hatzenbuhler NT; Evrard DA; Childers W; Harrison BL; Chlenov M; Hornby G; Smith DL; Sullivan KM; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2010 Jan; 20(1):222-7. PubMed ID: 19932965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
    Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
    Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
    J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 3-[4-(3-substituted phenyl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propanol derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Orús L; Martínez J; Pérez S; Oficialdegui AM; del Castillo JC; Mourelle M; Lasheras B; del Río J; Monge A
    Pharmazie; 2002 Aug; 57(8):515-8. PubMed ID: 12227188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
    Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
    J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.
    Herold F; Chodkowski A; Izbicki Ł; Turło J; Dawidowski M; Kleps J; Nowak G; Stachowicz K; Dybała M; Siwek A; Mazurek AP; Mazurek A; Pluciński F
    Eur J Med Chem; 2011 Jan; 46(1):142-9. PubMed ID: 21093118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.
    Ryckmans T; Berton O; Grimée R; Kogej T; Lamberty Y; Pasau P; Talaga P; Genicot C
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3195-8. PubMed ID: 12372532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist.
    Romero L; Celada P; Martín-Ruiz R; Díaz-Mataix L; Mourelle M; Delgadillo J; Hervás I; Artigas F
    Neuropsychopharmacology; 2003 Mar; 28(3):445-56. PubMed ID: 12629524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
    J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
    Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.